Antibiotic Susceptibility of Neisseria gonorrhoeae Isolates from Guangzhou, China, during 2002–2011
Antibiotic susceptibility of Neisseria gonorrhoeae in Guangzhou during 2002–2011 showed that resistance to penicillin and ciprofloxacin was high, while ceftriaxone remained effective although there was a trend towards reduced sensitivity.
Saved in:
Published in | Japanese Journal of Infectious Diseases Vol. 67; no. 4; pp. 288 - 291 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Japan
National Institute of Infectious Diseases, Japanese Journal of Infectious Diseases Editorial Committee
2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Antibiotic susceptibility of Neisseria gonorrhoeae in Guangzhou during 2002–2011 showed that resistance to penicillin and ciprofloxacin was high, while ceftriaxone remained effective although there was a trend towards reduced sensitivity. |
---|---|
AbstractList | Antibiotic susceptibility of Neisseria gonorrhoeae in Guangzhou during 2002–2011 showed that resistance to penicillin and ciprofloxacin was high, while ceftriaxone remained effective although there was a trend towards reduced sensitivity. Antibiotic susceptibility of Neisseria gonorrhoeae in Guangzhou during 2002-2011 showed that resistance to penicillin and ciprofloxacin was high, while ceftriaxone remained effective although there was a trend towards reduced sensitivity.Antibiotic susceptibility of Neisseria gonorrhoeae in Guangzhou during 2002-2011 showed that resistance to penicillin and ciprofloxacin was high, while ceftriaxone remained effective although there was a trend towards reduced sensitivity. |
Author | Wu, Xingzhong Lan, Yinyuan Zeng, Weiying Huang, Jinmei Zheng, Heping Yang, Bin Xue, Yaohua Tang, Sanmei Li, Yixin Qin, Xiaolin Ou, Jiangli |
Author_xml | – sequence: 1 fullname: Zheng, Heping organization: Guangdong Provincial Center for Skin Diseases and STD Control – sequence: 2 fullname: Yang, Bin organization: Guangdong Provincial Center for Skin Diseases and STD Control – sequence: 3 fullname: Wu, Xingzhong organization: Guangdong Provincial Center for Skin Diseases and STD Control – sequence: 4 fullname: Huang, Jinmei organization: Guangdong Provincial Center for Skin Diseases and STD Control – sequence: 5 fullname: Zeng, Weiying organization: Guangdong Provincial Center for Skin Diseases and STD Control – sequence: 6 fullname: Xue, Yaohua organization: Guangdong Provincial Center for Skin Diseases and STD Control – sequence: 7 fullname: Qin, Xiaolin organization: Guangdong Provincial Center for Skin Diseases and STD Control – sequence: 8 fullname: Lan, Yinyuan organization: Guangdong Provincial Center for Skin Diseases and STD Control – sequence: 9 fullname: Tang, Sanmei organization: Guangdong Provincial Center for Skin Diseases and STD Control – sequence: 10 fullname: Ou, Jiangli organization: Guangdong Provincial Center for Skin Diseases and STD Control – sequence: 11 fullname: Li, Yixin organization: Guangdong Provincial Center for Skin Diseases and STD Control |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25056075$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kc9uEzEQxi1URP_AjTPykUM2eNfrtfeEqghKpYoeCmdr7IwTl40dbO8hnPoOfUOehC0JQULiNDOa3zej-eacnIQYkJDXNZtLpfi7XfyGYd7JeaPUM3JWK9VWjeLdyZTztq06ztpTcp7zPWONEDV7QU4bwUTHpDgjeBmKNz4Wb-ndmC1un8rBlx2Njn5GnzMmD3QVQ0xpHRGQXuc4QMFMXYobejVCWP1Yx3FGF2sfYEaXY_JhRZtp38-Hx4bV9Uvy3MGQ8dUhXpCvHz98WXyqbm6vrheXN5UVoi8Vtn2zNACNUc6xXnIhmTDYG2bAWbCdROR1uwTHLTrWStlLdNIYdMYagfyCvN3P3ab4fcRc9MZPNw0DBIxj1rVoVcen4-sJfXNAR7PBpd4mv4G003-smYDZHrAp5pzQHZGa6Sfn9W_ndSf15PyEN__g1hcoPoaSwA__E73fi-5zgRUeN0Ca_jHgX7g9KI4du4akMfBfMM-iAQ |
CitedBy_id | crossref_primary_10_1016_j_diagmicrobio_2018_06_004 crossref_primary_10_1128_AAC_01211_15 crossref_primary_10_1186_s12879_016_2172_0 crossref_primary_10_7883_yoken_JJID_2016_522 crossref_primary_10_1039_D1QM01277K crossref_primary_10_1016_j_ijantimicag_2019_08_015 crossref_primary_10_1016_j_compositesb_2022_110384 crossref_primary_10_1371_journal_pone_0213312 crossref_primary_10_1186_s13018_021_02234_7 |
Cites_doi | 10.1586/eri.09.63 10.2807/ese.15.47.19721-en 10.1097/OLQ.0b013e3180ca8f24 10.1186/1471-2334-13-35 10.3201/eid1701.100397 10.7326/0003-4819-148-8-200804150-00005 10.1136/sti.79.5.399 10.1517/14656560902731993 10.1586/14787210.4.4.619 10.3201/eid1308.060948 10.2807/ese.16.14.19833-en 10.1128/AAC.05760-11 10.1155/2011/960501 10.1097/01.olq.0000137905.94154.0a 10.1186/1471-2334-13-40 10.1093/jac/dks162 |
ContentType | Journal Article |
Copyright | Authors |
Copyright_xml | – notice: Authors |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.7883/yoken.67.288 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1884-2836 |
EndPage | 291 |
ExternalDocumentID | 25056075 10_7883_yoken_67_288 article_yoken_67_4_67_288_article_char_en |
Genre | Journal Article |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GroupedDBID | --- .55 29J 2WC 3O- 53G 5GY 7.U AAUGY ACPRK ADBBV AENEX AFRAH ALMA_UNASSIGNED_HOLDINGS BAWUL DIK DU5 E3Z EBS EJD F5P FRP GX1 JSF JSH KQ8 OK1 RJT RNS RZJ TR2 W2D X7M XSB ZXP AAYXX CITATION OVT CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c559t-e492dbaa2b8ff09735705be9b0bafcac67ee314daf3cef047797ef7bbefbcb5e3 |
ISSN | 1344-6304 1884-2836 |
IngestDate | Fri Jul 11 03:27:19 EDT 2025 Mon Jul 21 05:49:31 EDT 2025 Tue Jul 01 05:08:17 EDT 2025 Thu Apr 24 23:09:54 EDT 2025 Thu Aug 17 20:30:47 EDT 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c559t-e492dbaa2b8ff09735705be9b0bafcac67ee314daf3cef047797ef7bbefbcb5e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/yoken/67/4/67_288/_article/-char/en |
PMID | 25056075 |
PQID | 1548635051 |
PQPubID | 23479 |
PageCount | 4 |
ParticipantIDs | proquest_miscellaneous_1548635051 pubmed_primary_25056075 crossref_primary_10_7883_yoken_67_288 crossref_citationtrail_10_7883_yoken_67_288 jstage_primary_article_yoken_67_4_67_288_article_char_en |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2014-00-00 |
PublicationDateYYYYMMDD | 2014-01-01 |
PublicationDate_xml | – year: 2014 text: 2014-00-00 |
PublicationDecade | 2010 |
PublicationPlace | Japan |
PublicationPlace_xml | – name: Japan |
PublicationTitle | Japanese Journal of Infectious Diseases |
PublicationTitleAlternate | Jpn J Infect Dis |
PublicationYear | 2014 |
Publisher | National Institute of Infectious Diseases, Japanese Journal of Infectious Diseases Editorial Committee |
Publisher_xml | – name: National Institute of Infectious Diseases, Japanese Journal of Infectious Diseases Editorial Committee |
References | 20. Zhong N, Zheng W, Wang F, et al. Analysis on the drug-resistance of Nersseria gonorrhoeae to Antibiotics in Hainan area from 2006-2011. Chin J Derm Venereol. 2013;27:56-7 (in Chinese). 27. Centers for Disease Control and Prevention. Cephalosporin susceptibility among Neisseria gonorrhoeae isolates–United States, 2000–2010. MMWR Morb Mortal Wkly Rep. 2011;60:873-7. 24. Barry PM, Klausner JD. The use of cephalosporins for gonorrhea: the impending problem of resistance. Expert Opin Pharmacother. 2009;10:555-77. 15. Chevalier B, Crenn Y, Cavallo JD, et al. Comparative activity of azithromycin against 100 strains of Neisseria gonorrhoeae. Pathol Biol (Paris). 1995;43:281-3. 17. Su X, Jiang F, Qimuge, et al. Surveillance of antimicrobial susceptibilities in Neisseria gonorrhoeae in Nanjing, China, 1999-2006. Sex Transm Dis. 2007;34:995-9. 3. Tapsall J. Antibiotic resistance in Neisseria gonorrhoeae is diminishing available treatment options for gonorrhea: some possible remedies. Expert Rev Anti Infect Ther. 2006;4:619-28. 5. Ison CA, Hussey J, Sankar KN, et al. Gonorrhoea treatment failures to cefixime and azithromycin in England. Euro Surveill. 2001;16:pii=19833. 28. Australian Gonococcal Surveillance Programme, Tapsall J. Annual report of the Australian Gonococcal Surveillance Programme, 2008. Commun Dis Intell Q Rep. 2009;33:268-74. 22. Olsen B, Pham TL, Golparian D, et al. Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from Vietnam, 2011. BMC Infect Dis. 2013;doi:10.1186/1471-2334-13-40. 11. Wu XZ, Zheng HP, Li YW, et al. In vitro susceptibility to six antimicrobial agents and the resistance plasmids genotype of Neisseria gorrhoeae isolates from four cities in Guangdong. J Diagn Ther Dermato–Venereol. 2012;19:352-5 (in Chinese). 8. Unemo M, Golparian D, Nicholas R, et al. High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother. 2012;56:1273-80. 1. Tapsall JW, Ndowa F, Lewis DA, et al. Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae. Expert Rev Anti Infect Ther. 2009;7:821-34. 6. Unemo M, Golparian D, Syversen G, et al. Two cases of verified clinical failures using internationally recommended first line cefixime for gonorrhoea treatment, Norway. Euro Surveill. 2010;15:pii=19721. 9. Ohnishi M, Saika T, Hoshina S, et al. Ceftriaxone-resistant Neisseria gonorrhoeae, Japan. Emerg Infect Dis. 2011;17:148-9. 12. NCSTD: Epidemiologic Reports of Syphilis and Gonorrheae Case Reports in China. [http://www.ncstdc.org/upfiles/201303/20130319152506703.pdf], accessed on 2012, 1 (in Chinese). 23. Sethi S, Golparian D, Bala M, et al. Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from India, Pakistan and Bhutan in 2007–2011. BMC Infect Dis. 2013;doi:10.1186/1471-2334-13-35. 13. Lau JT, Kim JH, Lau M, et al. Prevalence and risk behaviors of Hong Kong males who seek cross-border same-sex partners in mainland China. Sex Transm Dis. 2004;31:568-74. 4. Yokoi S, Deguchi T, Ozawa T, et al. Treat to cefixime treatment for gonorrhea. Emerg Infect Dis. 2007;13:1275-7. 10. Zheng HP, Cao WL, Wu XZ, et al. Antimicrobial susceptibility of Neisseria gonorrhoeae strains isolated in Guangzhou, China, 1996–2001. Sex Transm Infect. 2003;79:399-402. 29. Yan H, Yin YP, Dai XQ. Antimicrobial resistance in clinical isolates of Neisseria gonorrhoeae in China, 2008:an epidemiological study. Chin J Dermatol. 2011;44:472-5 (in Chinese). 19. Zhou X, Liu X, Zhang Z. Analysis of drug-resistance of Neisseria gonorrhoeae to antibiotics in Dalian from 2009-2011. China Health Care & Nutrition. 2013;1:388-9 (in Chinese). 7. Cámara J, Serra J, Ayats J, et al. Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain. J Antimicrob Chemother. 2012;67:1858-60. 2. Workowski KA, Berman SM, Douglas JM Jr. Emerging antimicrobial resistance in Neisseria gonorrhoeae: urgent need to strengthen prevention strategies. Ann Intern Med. 2008;148:606-13. 25. Kirkcaldy RD, Ballard RC, Dowell D. Gonococcal resistance: are cephalosporins next? Curr Infect Dis Rep. 2011;13:196-204. 14. World Health Organization (WHO). Sensitivity testing of Neisseria gonorrhoeae: Methodologies for use by participants in the WHO Western Pacific regional surveillance programme. In: WHO/WPRO Regional Antimicrobial Surevillance Working Group Meeting Proceedings. 1992;33-4. 18. Gu WM, Yang Y, Wu l. Surveillance on antibiotic susceptibility of Neisseria gonorrhoeae from 1988 to 2002 in Shanghai. Chin J Dermatol. 2004;37:323-5 (in Chinese). 26. Tapsall JW, Ndowa F, Lewis DA, et al. Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae. Exp Rev Anti Infect Ther. 2009;7:821-34. 21. Jabeen K, Nizamuddin S, Irfan S, et al. Increasing trend of resistance to penicillin, tetracycline, and fluoroquinolone resistance in Neisseria gonorrhoeae from Pakistan (1992–2009). J Trop Med, 2011; 960501. doi: 10.1155/2011/960501. 16. Van Dyck E, Piot P, Meheus A. Bench-level laboratory manual for sexually transmitted diseases, VDT/89.443. Geneva: World Health Organization (WHO). 1989. 22 23 24 25 26 27 28 29 10 11 12 13 14 15 16 17 18 19 1 2 3 4 5 6 7 8 9 20 21 |
References_xml | – reference: 28. Australian Gonococcal Surveillance Programme, Tapsall J. Annual report of the Australian Gonococcal Surveillance Programme, 2008. Commun Dis Intell Q Rep. 2009;33:268-74. – reference: 18. Gu WM, Yang Y, Wu l. Surveillance on antibiotic susceptibility of Neisseria gonorrhoeae from 1988 to 2002 in Shanghai. Chin J Dermatol. 2004;37:323-5 (in Chinese). – reference: 10. Zheng HP, Cao WL, Wu XZ, et al. Antimicrobial susceptibility of Neisseria gonorrhoeae strains isolated in Guangzhou, China, 1996–2001. Sex Transm Infect. 2003;79:399-402. – reference: 19. Zhou X, Liu X, Zhang Z. Analysis of drug-resistance of Neisseria gonorrhoeae to antibiotics in Dalian from 2009-2011. China Health Care & Nutrition. 2013;1:388-9 (in Chinese). – reference: 20. Zhong N, Zheng W, Wang F, et al. Analysis on the drug-resistance of Nersseria gonorrhoeae to Antibiotics in Hainan area from 2006-2011. Chin J Derm Venereol. 2013;27:56-7 (in Chinese). – reference: 26. Tapsall JW, Ndowa F, Lewis DA, et al. Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae. Exp Rev Anti Infect Ther. 2009;7:821-34. – reference: 6. Unemo M, Golparian D, Syversen G, et al. Two cases of verified clinical failures using internationally recommended first line cefixime for gonorrhoea treatment, Norway. Euro Surveill. 2010;15:pii=19721. – reference: 17. Su X, Jiang F, Qimuge, et al. Surveillance of antimicrobial susceptibilities in Neisseria gonorrhoeae in Nanjing, China, 1999-2006. Sex Transm Dis. 2007;34:995-9. – reference: 22. Olsen B, Pham TL, Golparian D, et al. Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from Vietnam, 2011. BMC Infect Dis. 2013;doi:10.1186/1471-2334-13-40. – reference: 25. Kirkcaldy RD, Ballard RC, Dowell D. Gonococcal resistance: are cephalosporins next? Curr Infect Dis Rep. 2011;13:196-204. – reference: 27. Centers for Disease Control and Prevention. Cephalosporin susceptibility among Neisseria gonorrhoeae isolates–United States, 2000–2010. MMWR Morb Mortal Wkly Rep. 2011;60:873-7. – reference: 21. Jabeen K, Nizamuddin S, Irfan S, et al. Increasing trend of resistance to penicillin, tetracycline, and fluoroquinolone resistance in Neisseria gonorrhoeae from Pakistan (1992–2009). J Trop Med, 2011; 960501. doi: 10.1155/2011/960501. – reference: 13. Lau JT, Kim JH, Lau M, et al. Prevalence and risk behaviors of Hong Kong males who seek cross-border same-sex partners in mainland China. Sex Transm Dis. 2004;31:568-74. – reference: 15. Chevalier B, Crenn Y, Cavallo JD, et al. Comparative activity of azithromycin against 100 strains of Neisseria gonorrhoeae. Pathol Biol (Paris). 1995;43:281-3. – reference: 23. Sethi S, Golparian D, Bala M, et al. Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from India, Pakistan and Bhutan in 2007–2011. BMC Infect Dis. 2013;doi:10.1186/1471-2334-13-35. – reference: 14. World Health Organization (WHO). Sensitivity testing of Neisseria gonorrhoeae: Methodologies for use by participants in the WHO Western Pacific regional surveillance programme. In: WHO/WPRO Regional Antimicrobial Surevillance Working Group Meeting Proceedings. 1992;33-4. – reference: 12. NCSTD: Epidemiologic Reports of Syphilis and Gonorrheae Case Reports in China. [http://www.ncstdc.org/upfiles/201303/20130319152506703.pdf], accessed on 2012, 1 (in Chinese). – reference: 8. Unemo M, Golparian D, Nicholas R, et al. High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother. 2012;56:1273-80. – reference: 16. Van Dyck E, Piot P, Meheus A. Bench-level laboratory manual for sexually transmitted diseases, VDT/89.443. Geneva: World Health Organization (WHO). 1989. – reference: 2. Workowski KA, Berman SM, Douglas JM Jr. Emerging antimicrobial resistance in Neisseria gonorrhoeae: urgent need to strengthen prevention strategies. Ann Intern Med. 2008;148:606-13. – reference: 7. Cámara J, Serra J, Ayats J, et al. Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain. J Antimicrob Chemother. 2012;67:1858-60. – reference: 29. Yan H, Yin YP, Dai XQ. Antimicrobial resistance in clinical isolates of Neisseria gonorrhoeae in China, 2008:an epidemiological study. Chin J Dermatol. 2011;44:472-5 (in Chinese). – reference: 3. Tapsall J. Antibiotic resistance in Neisseria gonorrhoeae is diminishing available treatment options for gonorrhea: some possible remedies. Expert Rev Anti Infect Ther. 2006;4:619-28. – reference: 9. Ohnishi M, Saika T, Hoshina S, et al. Ceftriaxone-resistant Neisseria gonorrhoeae, Japan. Emerg Infect Dis. 2011;17:148-9. – reference: 1. Tapsall JW, Ndowa F, Lewis DA, et al. Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae. Expert Rev Anti Infect Ther. 2009;7:821-34. – reference: 5. Ison CA, Hussey J, Sankar KN, et al. Gonorrhoea treatment failures to cefixime and azithromycin in England. Euro Surveill. 2001;16:pii=19833. – reference: 24. Barry PM, Klausner JD. The use of cephalosporins for gonorrhea: the impending problem of resistance. Expert Opin Pharmacother. 2009;10:555-77. – reference: 11. Wu XZ, Zheng HP, Li YW, et al. In vitro susceptibility to six antimicrobial agents and the resistance plasmids genotype of Neisseria gorrhoeae isolates from four cities in Guangdong. J Diagn Ther Dermato–Venereol. 2012;19:352-5 (in Chinese). – reference: 4. Yokoi S, Deguchi T, Ozawa T, et al. Treat to cefixime treatment for gonorrhea. Emerg Infect Dis. 2007;13:1275-7. – ident: 26 doi: 10.1586/eri.09.63 – ident: 18 – ident: 6 doi: 10.2807/ese.15.47.19721-en – ident: 12 – ident: 17 doi: 10.1097/OLQ.0b013e3180ca8f24 – ident: 16 – ident: 23 doi: 10.1186/1471-2334-13-35 – ident: 1 doi: 10.1586/eri.09.63 – ident: 14 – ident: 28 – ident: 9 doi: 10.3201/eid1701.100397 – ident: 2 doi: 10.7326/0003-4819-148-8-200804150-00005 – ident: 20 – ident: 10 doi: 10.1136/sti.79.5.399 – ident: 24 doi: 10.1517/14656560902731993 – ident: 3 doi: 10.1586/14787210.4.4.619 – ident: 4 doi: 10.3201/eid1308.060948 – ident: 5 doi: 10.2807/ese.16.14.19833-en – ident: 8 doi: 10.1128/AAC.05760-11 – ident: 21 doi: 10.1155/2011/960501 – ident: 11 – ident: 13 doi: 10.1097/01.olq.0000137905.94154.0a – ident: 19 – ident: 15 – ident: 29 – ident: 22 doi: 10.1186/1471-2334-13-40 – ident: 7 doi: 10.1093/jac/dks162 – ident: 27 – ident: 25 |
SSID | ssj0025510 |
Score | 2.031723 |
Snippet | Antibiotic susceptibility of Neisseria gonorrhoeae in Guangzhou during 2002–2011 showed that resistance to penicillin and ciprofloxacin was high, while... Antibiotic susceptibility of Neisseria gonorrhoeae in Guangzhou during 2002-2011 showed that resistance to penicillin and ciprofloxacin was high, while... |
SourceID | proquest pubmed crossref jstage |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 288 |
SubjectTerms | Anti-Bacterial Agents - pharmacology antibiotic Chi-Square Distribution China - epidemiology Cohort Studies Drug Resistance, Bacterial Gonorrhea - epidemiology Gonorrhea - microbiology Humans Microbial Sensitivity Tests Neisseria gonorrhoeae Neisseria gonorrhoeae - drug effects susceptibility |
Title | Antibiotic Susceptibility of Neisseria gonorrhoeae Isolates from Guangzhou, China, during 2002–2011 |
URI | https://www.jstage.jst.go.jp/article/yoken/67/4/67_288/_article/-char/en https://www.ncbi.nlm.nih.gov/pubmed/25056075 https://www.proquest.com/docview/1548635051 |
Volume | 67 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Japanese Journal of Infectious Diseases, 2014, Vol.67(4), pp.288-291 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF61BVVcEG_CS4sEp9QhidevY0GFtFJzoRURF8u7nk0M1K5S-0BP_Af-Ib-EmV3bcVArhV6syJ7Y653PszOz82DsjVaJj1q8clxNrhvlhU4ISjpKj0Gm4GvPBGMeT_3JqTiaebOt7d1O1FJVyoG6vDKv5CZcxXPIV8qS_Q_OtjfFE_gb-YtH5DAeN-Lxfk4ZHwXVXP1cXZgAFRPranbNp2C22rOkPy_yYrlcFJBA_xBHROqlzStBgOTzy0VR2Z33zCaI1amLFFjRxEK4tIKvKbK4yFLzyn5Hoz2sA7uqCyrqSfs-rcL-dQFWqEzgvFksSdbU3ur3WYvRL2Yss8yMa0U5qWrSI4pfyLrOitHKTTltXJtrMRBXjMsGCG_0Cv2DNKNKKsbLcnaWlSVAR5S7Qji-a5sbD8CeC0PhoELld-W_bQdS41x0hbltOFjrBWPbVezfJScIQyp98bP4DvnADwbtn9aKeNcQiQ1Z7AexoAPSxs0VSrJDTG-zW2M0eKgXx6dZG6yEdp-tq9G8k03hoGe_6z55Tbm6_Q3tizlcbzoZFerkHrtbTzPft2O5z7Ygf8B2j-vojocMVnjm63jmheYtnnkHz7zBMyc88xbPe9ygeY9bLHPC8p9fvwnFj9jpx4OTDxOnbgPiKDR3SwdENE5lkoxlqDVVl_KCoSchkkOZoKhRfgDgjkSaaFeBHoogiALQgZSgpZIeuI_ZTl7k8JTxJBXCA9Ryk5ESI5FEvgxEGqmhDKlTpe6xfjN_sapr5FOrlh8x2so02ysG4mz32NuW-tzWhrmGLrSsaKk2hkOPvW6YF6Pcp808_DLwI4jJ1YDGAq6pPfbEcrW9vTFr0BZ4dvMHP2d36Pu1zsYXbKdcVvAS1e9SvjLI_AvoRemM |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Antibiotic+Susceptibility+of+Neisseria+gonorrhoeae+Isolates+from+Guangzhou%2C+China%2C+during+2002%E2%80%932011&rft.jtitle=Japanese+Journal+of+Infectious+Diseases&rft.au=Zheng%2C+Heping&rft.au=Yang%2C+Bin&rft.au=Wu%2C+Xingzhong&rft.au=Huang%2C+Jinmei&rft.date=2014&rft.pub=National+Institute+of+Infectious+Diseases%2C+Japanese+Journal+of+Infectious+Diseases+Editorial+Committee&rft.issn=1344-6304&rft.eissn=1884-2836&rft.volume=67&rft.issue=4&rft.spage=288&rft.epage=291&rft_id=info:doi/10.7883%2Fyoken.67.288&rft.externalDocID=article_yoken_67_4_67_288_article_char_en |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1344-6304&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1344-6304&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1344-6304&client=summon |